Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-22-031172)

Filing Details

Accession Number:
0001209191-22-031172
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-20 19:19:31
Reporting Period:
2022-05-18
Accepted Time:
2022-05-20 19:19:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831915 Cytek Biosciences Inc. CTKB Laboratory Analytical Instruments (3826) 472547526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1874041 Ming Yan C/O Cytek Biosciences, Inc.
47215 Lakeview Boulevard
Fremont CA 94538		 Chief Technology Officer Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-18 2,642 $0.00 8,125,445 No 4 M Direct
Common Stock Disposition 2022-05-18 1,030 $9.65 8,124,415 No 4 F Direct
Common Stock Disposition 2022-05-19 20,000 $9.92 8,104,415 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-05-18 2,642 $0.00 2,642 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,066 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
  2. Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2021.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $10.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.